Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT07563595 · RECRUITING
Trial details
- NCT number
- NCT07563595
- Sponsor
- iOMEDICO AG
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-19
- Primary completion
- 2028-06-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.